Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Sarah Padgett

Physician Assistant Hickory, NC Physician Assistant

NPI 1881947646 CMS profile 10752979

2165 Medical Park Dr, Hickory, NC 28601

Open in the dashboard

General payments

$29,129

89 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarah Padgett of Hickory, NC is reported in the CMS Open Payments database as having received $29,129 across 89 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,253 56
2024 General $11,268 25
2023 General $273 4
2022 General $320 3
2021 General $16 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Padgett
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Sarah Padgett were reported at $17,253. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Sarah Padgett Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $16 $132 $37–$438 $132
2022 $320 $155 $48–$522 $149
2023 $273 $167 $52–$557 $160
2024 $11,268 $178 $55–$600 $164
2025 $17,253 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $19,424 50 payments
  2. Ethicon US, LLC $9,473 34 payments
  3. Zimmer Biomet Holdings, Inc. $149 1 payment
  4. DePuy Synthes Sales Inc. $55 2 payments
  5. Pacira Pharmaceuticals Incorporated $16 1 payment
  6. Supreme Orthopedic Systems, LLC $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $21,732 22 payments
  2. Travel and Lodging $5,191 19 payments
  3. Food and Beverage $1,736 44 payments
  4. Education $470 4 payments
Products named General payments · program years 2021–2025
  1. MONOVISC $990 6 payments
  2. ORTHOVISC $688 4 payments
  3. STRATAFIX $508 11 payments
  4. DERMABOND $301 4 payments
  5. DERMABOND PRINEO $239 5 payments
  6. VISTASEAL $125 5 payments
  7. SURGIFLO Hemostatic Matrix $53 3 payments
  8. EVARREST $50 2 payments
  9. ETHICON $29 3 payments
  10. Exparel $16 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

606

Median for Physician Assistant: 241

Drug cost

$4,887

Median for Physician Assistant: $4,110

Branded share of claims

3.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 100 $2,208
Mupirocin Generic 112 $771
Oxycodone Hcl Generic 109 $548
Meloxicam Generic 115 $433
Ibuprofen Generic 17 $384
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $204
Methocarbamol Generic 36 $117
Diclofenac Sodium Generic 16 $108
Amoxicillin Generic 62 $62
Tramadol Hcl Generic 18 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$112,375

Of which drugs: $52,709

Medicare patients

375

Average age 75

Services billed

1,665

238 women, 137 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 24%
Ischemic heart disease 23%
Diabetes 21%
Osteoporosis 20%
Atrial fibrillation 18%
Chronic kidney disease 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 69 279 $27,052
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 28 48 $25,488
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 78 233 $169

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record